Hester Biosciences Africa Limited (“Hester Africa”), a newly-formed Tanzanian company and a wholly-owned subsidiary of Hester Biosciences Limited (“Hester”), is building an animal vaccine manufacturing facility near Dar es Salaam. Hester has a 20-year track record manufacturing and distributing livestock drugs and vaccines to smallholder farmers in India and also manufactures vaccines in Nepal for government tenders. The foundation’s investment in Hester Africa will harness Hester’s expertise to reduce livestock mortality and morbidity by increasing access to and distribution of approximately ten high quality, low cost vaccines. In the long-term, Hester has the potential to prove that greenfield businesses, executed by experienced management with adequate, patient capital, can sustainably serve the foundation’s target population.